scientist at work

Our centers apply the fundamental knowledge gained from our programs to specific diseases.

The goal is to create the new therapeutics of tomorrow.

The Institute’s Cancer Center is one of only seven NCI-designated basic cancer research centers in the nation. We couple fundamental biological research with early translational studies to find new, innovative therapies that restore hope to cancer patients and their families.


 

Learn more

Obesity constitutes a global pandemic, with the number of overweight and obese people worldwide rising from 857 million in 1980 to 2.1 billion in 2013. Global projections show diabetes cases increasing from 171 million in 2000 to 366 million in 2030.

Learn more

The Center focuses on translational immunology research with an emphasis on bringing novel therapeutics for infectious diseases, autoimmune disorders and cancer to clinical trials.

Learn more

Diseases associated with aging and development are already a leading cause of death and disability, and their prevalence is rising fast—to give one example, by 2050, the number of Alzheimer’s patients age 65 and older may nearly triple from 5 million to 13.8 million.

Learn more

Genetic diseases in children are rare, and often incurable. Research insights into the genes and environmental factors that play a role in the development of childhood diseases is leading to better ways to more accurately diagnose, treat and cure children and young people with disease.

Learn more